In individuals with type 2 diabetes, liraglutide decreased CNS activation after short- but not long-term intervention, suggesting that these effects of GLP-1 RA on the CNS may contribute to the induction of weight loss [44]. This evidence concerns the gene GCG and type 2 diabetes mellitus.